Colucci, Dennis AuD, MAThe Hearing Journal:February 2017 – Volume 70 – Issue 2 – p 42,44,45 doi: 10.1097/01.HJ.0000513103.95086.22Hearing Matters IMPORTANCE OF EARLY INTERVENTION Regardless of the cause or network mechanisms involved, intense and early treatment is a critical part of the therapy to improve sleep, control headaches or migraines, and the associated anxiety, in addition […]
Authors; Ibrahim Almufarrij, Kevin J. Munro, Piers Dawes, Michael A. Stone, and Harvey Dillon Abstract; Direct-to-consumer (DTC) hearing devices can be purchased without consulting a hearing health professional. This project aims to compare 28 DTC devices with the most popular hearing aid supplied by the U.K. National Health Service (NHS). The comparison was based on […]
DAVID NIELD 23 JUN 2019 “Dosing medicines can be a tricky process: How much of a medication actually ends up hitting its target can vary a lot between patients, sometimes for mysterious reasons. As it turns out, even the things living in our bodies could be gobbling up our drugs.” Read more https://www.sciencealert.com/gut-microbes-could-be-eating-up-our-meds-before-they-get-chance-to-work The research […]
New research that aimed to highlight the potential of new technologies to diagnose disease has suggested that virtual reality may play a crucial role in monitoring Alzheimer’s disease.
Transneuronal Propagation of Pathologic Î±-Synuclein from the Gut to the Brain Models Parkinson’s Disease Published: June 26, 2019 DOI: https://doi.org/10.1016/j.neuron.2019.05.035 Interview with Ted Dawson discussing his lab’s demonstration that misfolded Î±-synuclein which can move from the stomach to the brain and cause physical and cognitive symptoms.: https://www.the-scientist.com/news-opinion/mouse-model-shows-how-parkinsons-disease-begins-in-the-gut-66048
Cheryl E. G. Leyns, Maud Gratuze, Sneha Narasimhan, Nimansha Jain, Lauren J. Koscal, Hong Jiang, Melissa Manis, Marco Colonna, Virginia M. Y. Lee, Jason D. Ulrich & David M. Holtzman Nature Neuroscience (2019) Abstract Variants in the triggering receptor expressed on myeloid cells 2 (TREM2) have been associated with increased risk for sporadic, late-onset Alzheimer’s […]